Drug profile · INN
rifamycin sodium
AEMCOLO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
rifamycin sodium (AEMCOLO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN rifamycin sodium
Brand AEMCOLO
Route ORAL
Formulation TABLET, DELAYED RELEASE
Frequently asked questions
What is rifamycin sodium?
rifamycin sodium (AEMCOLO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for rifamycin sodium?
AEMCOLO is a marketed brand name for rifamycin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of rifamycin sodium?
rifamycin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.